6-(Trifluoromethyl)indoline | CAS:181513-29-1

We serve 6-(Trifluoromethyl)indoline CAS:181513-29-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
6-(Trifluoromethyl)indoline

Chemical Name:6-(Trifluoromethyl)indoline
CAS.NO:181513-29-1
Synonyms:6-(Trifluoromethyl)indoline
6-(trifluoromethyl)-2,3-dihydro-1H-indole
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 221.4±40.0 °C at 760 mmHg
Molecular Formula C9H8F3N
Molecular Weight 187.162
Flash Point 87.7±27.3 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.481
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 6-(Trifluoromethyl)indoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-(trifluoromethyl)-2,3-dihydro-1H-indole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-(Trifluoromethyl)indoline Use and application,6-(trifluoromethyl)-2,3-dihydro-1H-indole technical grade,usp/ep/jp grade.


Related News: “Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol manufacturer “Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.Sulfuryl dichloride supplier British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.2-Bromo-2-methylpropane vendor It is delivered to hospitals and pharmacies until it reaches the patient.Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.